Active — Not RecruitingNot Applicable

Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery

Taiwan260 participantsStarted 2025-09-08

Plain-language summary

In study phase 1, the investigators will prospectively examine the factors related to post-operative glycemic variability and its effect on outcomes in people with both DM and GI cancer after surgery. The study will also qualitatively understand the glycemic variability experiences and their associated symptoms and outcomes in people with both DM and GI cancer. In study phase 2, the investigators will develop and test the effects of the CGM-Assisted Reflection Education (CARE) program on adults with both DM and GI cancer post-surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals who are planning to undergo GI cancer surgery according to their physician's advice * Diagnosed with diabetes mellitus * Aged 18 or above * Can communicate in Mandarin or Taiwanese * Agree to participate and sign the informed consent form Exclusion Criteria: * People who are under active treatment for cancer other than GI cancer * Have a cognitive impairment * Do not know that they have GI cancer * Have medical-grade adhesives-related allergy (e.g., redness, swelling, heat, pain, itching, blisters or rash) * Diagnosed with thrombocytopenia or blood coagulation dysfunction

What they're measuring

Self-Care of Diabetes Inventory

Timeframe: before surgery (T0), 3 (T1), 6 (T2), and 12 (T3) months post-surgery

Trial details

NCT IDNCT07180251

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-07-31

View on ClinicalTrials.gov More Diabetes Melletus trials